Julius Strauss

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 35 papers. Top paper: “Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies”.

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001395

N/A

3.6DataRank · unranked

159 citations

Margaret E. Gatti‐Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward F. McClay +18 more

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005813

N/A

0.810DataRank · unranked

25 citations

Jean‐Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K. Pachynski +14 more

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Avelumab in Patients With Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad162

N/A

0.332DataRank · unranked

6 citations

Geraldine O’Sullivan Coyne, Clay T. Reed, Ravi A. Madan, Julius Strauss, Seth J Steinberg +5 more

PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.105

N/A

0DataRank · unranked

7 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +10 more

Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17569

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +13 more

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2501

N/A

0DataRank · unranked

20 citations

Charalampos S. Floudas, Houssein Abdul Sater, Michell Manu, Elizabeth Lamping, Deneise C Francis +15 more

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5096

N/A

0DataRank · unranked

3 citations

Marijo Bilušić, Fatima Karzai, Lisa M. Cordes, Julius Strauss, Houssein Abdul Sater +10 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

CD4+ T-cell count eligibility by HIV status among participants receiving immunotherapy for cancer diagnoses.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12104

N/A

0DataRank · unranked

2 citations

Matthew Rosenthal, Kathryn Lurain, Julius Strauss, Thomas S. Uldrick, James L. Gulley +3 more

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2617

N/A

0DataRank · unranked

0 citations

Katherine Lee-Wisdom, Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Claudia Palena +14 more

6 Immune correlates of clinical benefit in patients with HPV-associated malignancies treated with bintrafusp alfa

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.006

N/A

0DataRank · unranked

0 citations

Renee N. Donahue, Nicole J. Toney, Julius Strauss, James L. Gulley, Jeffrey Schlom +1 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status

Experimental Biology and Medicine(2022)10.1177/15353702221089910

N/A

0DataRank · unranked

31 citations

Julius Strauss, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro

Non-synergy of PD-1 blockade with T-cell therapy in solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004906

N/A

0DataRank · unranked

17 citations

Farrah Karimipour, Ling Zhang, Nisha Nagarsheth, Scott M. Norberg, Carylinda Serna +5 more

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005128

N/A

0DataRank · unranked

13 citations

Kathryn Lurain, Julius Strauss, Steven P. Fling, Elad Sharon, Anna K. Wright +8 more

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.07.495219

N/A

0DataRank · unranked

9 citations

Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis, Katherine Caley +25 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12

International Immunopharmacology(2023)10.1016/j.intimp.2023.109736

N/A

0DataRank · unranked

9 citations

Margaret E. Gatti‐Mays, Nicholas Tschernia, Julius Strauss, James L. Gulley, Jeffrey Schlom +2 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

Research Square(2023)10.21203/rs.3.rs-3193270/v1

N/A

0DataRank · unranked

6 citations

Danh-Tai Hoang, Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +25 more

Phase II evaluation of combination immunotherapy with CV301, N-803, bintrafusp alfa, and M9241 in patients with advanced small bowel and colorectal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.116

N/A

0DataRank · unranked

4 citations

Jason M. Redman, Charalampos S. Floudas, Elizabeth Lamping, Deneise C Francis, Lisa M. Cordes +5 more

Deep Learning Model Imputes Missing Stains in Multiplex Images

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.21.568088

N/A

0DataRank · unranked

4 citations

Wiem Lassoued, Kenneth Canubas, Shania Bailey, Yanling Liu, Clint Allen +7 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

Nature Cancer(2024)10.1038/s43018-024-00793-2

N/A

0DataRank · unranked

141 citations

Gal Dinstag, Eldad D. Shulman, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +26 more

Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy

JAAD Case Reports(2024)10.1016/j.jdcr.2024.09.029

N/A

0DataRank · unranked

3 citations

Vincent Poon, Patrick Hallaert, Deneise C Francis, Danielle M. Pastor, Leslie Castelo-Soccio +3 more

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000433

N/A

0DataRank · unranked

247 citations

Sofia R. Gameiro, Caroline Jochéms, Renee N. Donahue, Julius Strauss, James L. Gulley +3 more

Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.0032

N/A

0DataRank · unranked

25 citations

Sandra G. Williams, Lawrence Yao, Suresh Maharjan, Julius Strauss, Elad Sharon +9 more

Case Report: Severe Toxicity in an African–American Patient Receiving FOLFOX Carrying Uncommon Allelic Variants in DPYD

Pharmacogenomics(2020)10.2217/pgs-2020-0120

N/A

0DataRank · unranked

8 citations

Lisa M. Cordes, Cody J. Peer, Shruti U. Gandhy, Jason M. Redman, Julius Strauss +2 more

A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in locally advanced, unresectable, chordoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11527

N/A

0DataRank · unranked

9 citations

Marijo Bilušić, Deric Park, Christopher R. Heery, Ravi A. Madan, Julius Strauss +7 more